Legend Biotech Corp (LEGN)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $17.88
- As of
Kresmion compiles this page from LEGN's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Legend Biotech Corp (LEGN): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-10-15.
See the full LEGN dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for LEGN on one page. Preview it with sample data, then open it live with a free account.
Preview the LEGN dossierActive signals for LEGN
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 17.8%, EPS $0.09 vs $0.0764 estimate
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +95% to LEGN (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 52% of LEGN (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +63% to LEGN (2026Q2)
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +92% to LEGN (2026Q2)
FREE, NO ACCOUNT
Every signal on LEGN, as it fires
You are seeing 5 of 12 signals recorded on LEGN since 2026-06-02.
The five above landed across 2 days. The other 7 were recorded on 2 other days. 7 of the 12 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in LEGN (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| Point72 Asset Management, L.P.CUSIP 52490G102 · 2026Q2 | $88.8M | 0.10% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 52490G102 · 2026Q2 | $28.9M | 0.04% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 52490G102 · 2026Q2 | $4.7M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 52490G102 · 2026Q2 | $986K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, LEGN
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
LEGN against its peers
LEGN's operating margin of -13.3% ranks in the 62nd percentile of 16 Biotechnology sub-industry peers, fiscal period ending 2025-12-31.
| Metric | LEGN | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.0B USD | 101M USD | 92 | 18 |
| Revenue YoY | 64.0% | n/a | n/a | 0 |
| Operating margin | -13.3% | -125.6% | 62 | 16 |
| Net margin | -28.8% | -54.6% | 62 | 16 |
| Return on equity | -29.6% | -30.7% | 50 | 24 |
| 1 year | n/a | 30.6% | n/a | 20 |
Peers (24): VKTX, VCYT, XENE, IDYA, TLX, ACAD, CPRX, GRTX, RLAY, ARQT, CELC, TNGX, DNLI, DYN, EWTX, RCUS, ELVN, DNTH, ZLAB, PGEN, ATAI, TVTX, BEAM, DFTX. Left out: PBLS (no annual filing). Fiscal period ending 2025-12-31. Every figure is one full fiscal year read from one annual filing (LEGN: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow LEGN on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to LEGN for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.